Search Results - "Tung, Stewart Y."

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial by Chan, Anthony T C, Hui, Edwin P, Ngan, Roger K C, Tung, Stewart Y, Cheng, Ashley C K, Ng, Wai T, Lee, Victor H F, Ma, Brigette B Y, Cheng, Hoi C, Wong, Frank C S, Loong, Herbert H F, Tong, Macy, Poon, Darren M C, Ahuja, Anil T, King, Ann D, Wang, Ki, Mo, Frankie, Zee, Benny C Y, Chan, K C Allen, Lo, Y M Dennis

“…Purpose The contribution of adjuvant chemotherapy after chemoradiation therapy (CRT) in nasopharyngeal cancer (NPC) remains controversial. Plasma Epstein-Barr…”
Get full text

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting by Yang, Xuesong, Dai, Wei, Kwong, Dora Lai‐wan, Szeto, Carol Y.Y., Wong, Elibe Hiu‐wun, Ng, Wai Tong, Lee, Anne W.M., Ngan, Roger K.C., Yau, Chun Chung, Tung, Stewart Y., Lung, Maria Li

“…Nasopharyngeal carcinoma (NPC) is a human malignancy that is closely associated with Epstein‐Barr Virus (EBV). Early diagnosis of NPC will greatly improve the…”
Get full text

Clinical Outcomes of 174 Nasopharyngeal Carcinoma Patients With Radiation-Induced Temporal Lobe Necrosis by Lam, Tai-Chung, F.R.C.R, Wong, Frank C.S., F.R.C.R, Leung, To-Wai, M.D, Ng, S.H., F.R.C.P, Tung, Stewart Y., F.R.C.R

“…Purpose To retrospectively study the clinical outcomes of nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis (TLN) treated with…”
Get full text

Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group by LEE, Anne W. M, LAU, W. H, NGAN, Roger K. C, LAW, Stephen C. K, YAU, T. K, AU, Joseph S. K, O'SULLIVAN, Brian, PANG, Ellie S. Y, O, S. K, AU, Gordon K. H, LAU, Joseph T, TUNG, Stewart Y, CHUA, Daniel T. T, CHAPPELL, Rick, XU, L, SIU, Lillian, SZE, W. M, LEUNG, T. W, SHAM, Jonathan S. T

“…This randomized study compared the results achieved by concurrent chemoradiotherapy (CRT) versus radiotherapy (RT) alone for nasopharyngeal carcinoma (NPC)…”
Get full text

Whole-Field Simultaneous Integrated-Boost Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma by Wong, Frank C.S., F.R.C.R, Ng, Alice W.Y., F.R.C.R, Lee, Victor H.F., F.R.C.R, Lui, Collin M.M., B.Sc, Yuen, Kwok-Keung, F.R.C.R, Sze, Wing-Kin, F.R.C.R, Leung, To-Wai, M.D, Tung, Stewart Y., F.R.C.R

“…Purpose To retrospectively review the outcomes of our patients with newly diagnosed nondisseminated nasopharyngeal carcinoma treated with intensity-modulated…”
Get full text

Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer – report on clinical outcome and dose to critical organs by Ng, Alice W.Y, Tung, Stewart Y, Wong, Victy Y.W

“…Abstract We report 20 cases using hypofractionation stereotactic radiotherapy in medically inoperable stage I non-small cell lung cancer with dose escalation…”
Get full text

Stereotactic Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma by Leung, To-Wai, M.D, Wong, Victy Y.W., M.Sc, Tung, Stewart Y., F.R.C.R

“…Purpose To study the treatment outcome in patients with locally recurrent nasopharyngeal carcinoma (NPC) who were treated with stereotactic radiotherapy (SRT)…”
Get full text

High-Dose-Rate Intracavitary Brachytherapy Boost for Early T Stage Nasopharyngeal Carcinoma{PRIVATE} by Leung, To-Wai, F.R.C.R, Wong, Victy Y.W., M.Sc, Sze, Wing-Kin, F.R.C.R, Lui, Collin M.M., B.Sc, Tung, Stewart Y., F.R.C.R

“…Purpose To investigate any possible therapeutic gain from dose escalation with brachytherapy for early T stage nasopharyngeal carcinoma (NPC). Methods and…”
Get full text

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study) by Au, K.H., Ngan, Roger K.C., Ng, Alice W.Y., Poon, Darren M.C., Ng, W.T., Yuen, K.T., Lee, Victor H.F., Tung, Stewart Y., Chan, Anthony T.C., Sze, Henry C.K., Cheng, Ashley C.K., Lee, Anne W.M., Kwong, Dora L.W., Tam, Anthony H.P.

“…•Treatment outcomes of 3328 NPC patient treated with IMRT in Hong Kong.•8 year local/regional control remained promising.•Confirmed benefits of concurrent…”
Get full text

Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time by Lee, Anne W M, Kwong, Dora L W, Leung, Sing Fai, Tung, Stewart Y, Sze, Wai Man, Sham, Jonathan S T, Teo, Peter M L, Leung, To Wai, Wu, Po Man, Chappell, Rick, Peters, Lester J, Fowler, John F

“…To study the factors affecting the risk of symptomatic temporal lobe necrosis after different fractionation schedules. One thousand thirty-two patients with…”
Get more information

Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG) by Teo, Peter M.L., Leung, Sing Fai, Tung, Stewart Y., Zee, Benny, Sham, Jonathan S.T., Lee, Anne W.M., Lau, Wai Hon, Kwan, Wing Hong, Leung, To Wai, Chua, Daniel, Sze, Wai Man, Au, Joseph S.K., Yu, Kwok Hung, O, Sai Ki, Kwong, Dora, Yau, Tsz Kok, Law, Stephen C.K., Sze, Wing Kin, Au, Gordon, Chan, Anthony T.C.

“…To define the dose–response relationship of nasopharyngeal carcinoma (NPC) above the conventional tumoricidal dose level of 66Gy when the basic radiotherapy…”
Get full text

Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma by Lee, Anne W.M., Ngan, Roger K.C., Tung, Stewart Y., Cheng, Ashley, Kwong, Dora L.W., Lu, Tai‐Xiang, Chan, Anthony T.C., Chan, Lucy L.K., Yiu, Harry, Ng, Wai‐Tong, Wong, Frank, Yuen, Kam‐Tong, Yau, Stephen, Cheung, Foon‐Yiu, Chan, Oscar S.H., Choi, Horace, Chappell, Rick

“…BACKGROUND A current recommendation for locoregionally advanced nasopharyngeal carcinoma (NPC) is conventional fractionated radiotherapy with concurrent…”
Get full text

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity by Lee, Anne W. M., Tung, Stewart Y., Ng, Wai Tong, Lee, Victor, Ngan, Roger K. C., Choi, Horace C. W., Chan, Lucy L. K., Siu, Lillian L., Ng, Alice W. Y., Leung, To Wai, Yiu, Harry H. Y., O'Sullivan, Brian, Chappell, Rick

“…BACKGROUND Concurrent‐adjuvant chemoradiotherapy (CRT) became a recommended treatment for locoregionally advanced nasopharyngeal carcinoma (NPC) with the first…”
Get full text

NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma by Lee, Anne W. M., Ngan, Roger K. C., Ng, Wai‐Tong, Tung, Stewart Y., Cheng, Ashley A. C., Kwong, Dora L. W., Lu, Tai‐Xiang, Chan, Anthony T. C., Sze, Henry C. K., Yiu, Harry H. Y., Wong, Frank C. S., Yuen, Kam‐Tong, Chappell, Rick, Choi, Horace C. W.

“…Background A current recommendation for the treatment of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) is conventional fractionated…”
Get full text

Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma by Leung, T W, Tung, S Y, Sze, W K, Sze, W M, Wong, V Y, Wong, C S, O, S K

“…To study the treatment outcome in patients with locally recurrent nasopharyngeal carcinoma (NPC) and to explore whether a combination of high-dose-rate (HDR)…”
Get more information

Randomized Trial of Radiotherapy Plus Concurrent–Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma by Lee, Anne W. M., Tung, Stewart Y., Chua, Daniel T. T., Ngan, Roger K. C., Chappell, Rick, Tung, Raymond, Siu, Lillian, Ng, W. T., Sze, W. K., Au, Gordon K. H., Law, Stephen C. K., O'Sullivan, Brian, Yau, T. K., Leung, T. W., Au, Joseph S. K., Sze, W. M., Choi, C. W., Fung, K. K., Lau, Joseph T., Lau, W. H.

“…Background Current practice of adding concurrent–adjuvant chemotherapy to radiotherapy (CRT) for treating advanced nasopharyngeal carcinoma is based on the…”
Get full text

Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma by Ng, Wai-Tong, Ngan, Roger K.C., Kwong, Dora L.W., Tung, Stewart Y., Yuen, Kam-Tong, Kam, Michael K.M., Sze, Henry C.K., Yiu, Harry H.Y., Chan, Lucy L.K., Lung, Maria L., Lee, Anne W.M.

“…To evaluate, in a phase 2 study, whether induction docetaxel, cisplatin, and fluorouracil (TPF) followed by weekly docetaxel and cetuximab in concurrence with…”
Get full text

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials by Lee, Anne W.M, Tung, Stewart Y, Ngan, Roger K.C, Chappell, Rick, Chua, Daniel T.T, Lu, T.X, Siu, Lillian, Tan, Terence, Chan, L.K, Ng, W.T, Leung, T.W, Fu, Y.T, Au, Gordon K.H, Zhao, C, O’Sullivan, Brian, Tan, E.H, Lau, W.H

“…Abstract Background The current standard treatment for locoregionally advanced nasopharyngeal carcinoma (NPC) was conventional–fractionation radiotherapy plus…”
Get full text

Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma—Exploration for Achieving Optimal 10-Year Therapeutic Ratio by Ng, Wai-Tong, Tung, Stewart Y., Lee, Victor, Ngan, Roger K.C., Choi, Horace C.W., Chan, Lucy L.K., Leung, To-Wai, Siu, Lillian L., Lu, Tai-Xiang, Tan, Terence, Tan, Eng-Huat, Sze, Henry C.K., Ng, Alice W.Y., Yiu, Harry H.Y., O'Sullivan, Brian, Chappell, Rick, Lee, Anne W.M.

“…This is an updated combined analysis of 2 randomized studies (NPC-9901 and NPC-9902 trials) to evaluate the 10-year outcome attributed to the addition…”
Get full text

Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience by Lee, Anne W M, Sze, W M, Au, Joseph S K, Leung, S F, Leung, T W, Chua, Daniel T T, Zee, Benny C Y, Law, Stephen C K, Teo, Peter M L, Tung, Stewart Y, Kwong, Dora L W, Lau, W H

“…To analyze the treatment results achievable for nasopharyngeal carcinoma in the modern era to identify the key failures for future improvement and to provide…”
Get more information